Supernus Pharmaceuticals Inc (SUPN)
Operating return on assets (Operating ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -1 | 46,124 | 86,029 | 173,698 | 148,571 |
| Total assets | US$ in thousands | 1 | 1,702,510 | 1,689,150 | 1,504,100 | 1,160,280 |
| Operating ROA | -100.00% | 2.71% | 5.09% | 11.55% | 12.80% |
December 31, 2023 calculation
Operating ROA = Operating income ÷ Total assets
= $-1K ÷ $1K
= -100.00%
The operating return on assets (ROA) of Supernus Pharmaceuticals Inc has shown a declining trend over the past five years, decreasing from 12.80% in 2019 to 1.05% in 2023. This decline indicates a decrease in the company's ability to generate operating income from its assets. The decreasing trend could be a cause for concern as it suggests less efficient utilization of assets to generate operating profits. This may be due to various factors such as increased operating expenses, lower revenue generation, or inefficient asset management. It is important for Supernus Pharmaceuticals Inc to closely monitor its operating ROA and implement strategies to improve asset efficiency and profitability in order to enhance overall financial performance.
Peer comparison
Dec 31, 2023